190 related articles for article (PubMed ID: 2821617)
1. Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice.
Ornitz DM; Hammer RE; Messing A; Palmiter RD; Brinster RL
Science; 1987 Oct; 238(4824):188-93. PubMed ID: 2821617
[TBL] [Abstract][Full Text] [Related]
2. Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer.
Levine DS; Sanchez CA; Rabinovitch PS; Reid BJ
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6427-31. PubMed ID: 1650467
[TBL] [Abstract][Full Text] [Related]
3. Elastase I promoter directs expression of human growth hormone and SV40 T antigen genes to pancreatic acinar cells in transgenic mice.
Ornitz DM; Palmiter RD; Messing A; Hammer RE; Pinkert CA; Brinster RL
Cold Spring Harb Symp Quant Biol; 1985; 50():399-409. PubMed ID: 3006998
[No Abstract] [Full Text] [Related]
4. Hyperplasia and tumors of the islets of Langerhans in mice bearing an elastase I-SV40 T-antigen fusion gene.
Bell RH; Memoli VA; Longnecker DS
Carcinogenesis; 1990 Aug; 11(8):1393-8. PubMed ID: 2167183
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of streptozotocin on tumor development in transgenic mice bearing an elastase I-SV40 T-antigen fusion gene.
Bell RH; Brinck-Johnsen T; Longnecker DS
Pancreas; 1991 Jul; 6(4):475-8. PubMed ID: 1678889
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of p53 and the development of tetraploidy in the elastase-SV40 T antigen transgenic mouse pancreas.
Ramel S; Sanchez CA; Schimke MK; Neshat K; Cross SM; Raskind WH; Reid BJ
Pancreas; 1995 Oct; 11(3):213-22. PubMed ID: 8577673
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mice carrying a murine amylase 2.2/SV40 T antigen fusion gene develop pancreatic acinar cell and stomach carcinomas.
Ceci JD; Kovatch RM; Swing DA; Jones JM; Snow CM; Rosenberg MP; Jenkins NA; Copeland NG; Meisler MH
Oncogene; 1991 Feb; 6(2):323-32. PubMed ID: 1705690
[TBL] [Abstract][Full Text] [Related]
9. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene.
Sepulveda AR; Finegold MJ; Smith B; Slagle BL; DeMayo JL; Shen RF; Woo SL; Butel JS
Cancer Res; 1989 Nov; 49(21):6108-17. PubMed ID: 2551499
[TBL] [Abstract][Full Text] [Related]
10. A morphological analysis endocrine tumour genesis in pancreas and anterior pituitary of AVP/SV40 transgenic mice.
Rindi G; Bishop AE; Murphy D; Solcia E; Hogan B; Polak JM
Virchows Arch A Pathol Anat Histopathol; 1988; 412(3):255-66. PubMed ID: 2829418
[TBL] [Abstract][Full Text] [Related]
11. Coordinate expression of the endogenous p53 gene in beta cells of transgenic mice expressing hybrid insulin-SV40 T antigen genes.
Efrat S; Baekkeskov S; Lane D; Hanahan D
EMBO J; 1987 Sep; 6(9):2699-704. PubMed ID: 2824189
[TBL] [Abstract][Full Text] [Related]
12. SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice.
Palmiter RD; Chen HY; Messing A; Brinster RL
Nature; 1985 Aug 1-7; 316(6027):457-60. PubMed ID: 2991771
[TBL] [Abstract][Full Text] [Related]
13. Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice.
Ye X; McCarrick J; Jewett L; Knowles BB
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3916-20. PubMed ID: 8171012
[TBL] [Abstract][Full Text] [Related]
14. A simian virus 40 large T-antigen segment containing amino acids 1 to 127 and expressed under the control of the rat elastase-1 promoter produces pancreatic acinar carcinomas in transgenic mice.
Tevethia MJ; Bonneau RH; Griffith JW; Mylin L
J Virol; 1997 Nov; 71(11):8157-66. PubMed ID: 9343166
[TBL] [Abstract][Full Text] [Related]
15. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
Grippo PJ; Sandgren EP
Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
[TBL] [Abstract][Full Text] [Related]
16. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.
Grippo PJ; Nowlin PS; Demeure MJ; Longnecker DS; Sandgren EP
Cancer Res; 2003 May; 63(9):2016-9. PubMed ID: 12727811
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors.
Brinster RL; Chen HY; Messing A; van Dyke T; Levine AJ; Palmiter RD
Cell; 1984 Jun; 37(2):367-79. PubMed ID: 6327063
[TBL] [Abstract][Full Text] [Related]
18. Peripheral neuropathies, hepatocellular carcinomas and islet cell adenomas in transgenic mice.
Messing A; Chen HY; Palmiter RD; Brinster RL
Nature; 1985 Aug 1-7; 316(6027):461-3. PubMed ID: 2991772
[TBL] [Abstract][Full Text] [Related]
19. Methods to assess inhibition of adipocyte differentiation by SV40 large T antigen.
Higgins C; Cherington V
Methods Mol Biol; 2001; 165():165-83. PubMed ID: 11217384
[No Abstract] [Full Text] [Related]
20. Stimulation of simian virus 40 late gene expression by simian virus 40 tumor antigen.
Brady J; Bolen JB; Radonovich M; Salzman N; Khoury G
Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2040-4. PubMed ID: 6201850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
